Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This trial will evaluate the clinical significance of the PRO Onc assay and will assess the efficacy of HER2-targeted therapy in patients with HER2-negative breast cancer who have been identified as having HER2 overexpression/activation by the PRO Onc Assay.
Critère d'inclusion
- Breast Cancer